TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in peak walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom severity (total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days at home in the last 180 days of life
Endpoint domain: Mortality/survival
Primary endpoint: Caregiver preparedness for caregiving
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Control of serum phosphorus levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functionality on Instrumental Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functionality on Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Regression of anogenital warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants with B. pertussis by PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Vaccination status at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net cost offset of intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in TB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change Acid Fast Bacilli (AFB) smear (Sputum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in chest X-ray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life-adjusted early disease control
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Biochemical (PSA) Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in mean heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dilation of extra- and intracerebral arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participation in cervical cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete molecular response (CMR) rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with PSA response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steps walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Abnormalities in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Average Total Urine Output at End of Treatment (EOT) of Last Cycle During Teduglutide Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: video transmission image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: audio transmission quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events (AE)/serious adverse events (SAE)/Dose Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular itching and redness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Participants With at Least a 3 Point Drop in the Short Clinical Colitis Score (SCCAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Coefficient of Fat Absorption in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent change in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum PCT level measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Ammonia Levels at the Peak and Mean TNUAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Experienced Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Experienced Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients Demonstrating Objective Response (PR+CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to radiologic healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery System Success Rate (DSSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attenuation of myocardial injury assessed by Cardiac Troponin I levels (cTnI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Canine root resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Percentage of Patients Who Had a Curative (R0) Liver Metastasectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mortality related to cardiovascular disease
Endpoint domain: Mortality/survival
Primary endpoint: Smoking Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Reported Smoker Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Abdominal Fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of treatment failures within 6 months after beginning radiochemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival after RCT
Endpoint domain: Mortality/survival
Primary endpoint: Fatty acid composition in whole-blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum tolerated dose of capecitabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase II dose of capecitabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of embolization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose limiting adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: plasma choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: homocysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VOC pattern identification for gastric cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Annualized Relapse Rate (ARR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Efficacy of Tattoo Removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gingival and periodontal phenotype determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of follicles > 12 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative failure rate
Endpoint domain: Mortality/survival
Primary endpoint: 6-minute Walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability due to low back pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants With CMV Viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Behavior and knowledge score of families
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colorectal Adenoma Occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Advanced Neoplasia Occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Colorectal Cancer Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mitochondrial Reserve Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to therapy by assessment of remaining pills/medication claims electronic records
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to therapy according to ProMas
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to therapy according to MS-TAQ
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in non-HDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Objectively measured hours of exercise/month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of advanced colonic adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Digital Volume Pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood platelet MAO-B activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Live birth rates per transfer
Endpoint domain: Mortality/survival
Primary endpoint: International Restless Legs Syndrome Study Group (IRLSSG) Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in retinal anatomy (size of FVPED, sub-retinal fluid and retinal volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain evolution on analogic visual scale (EVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOSI Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Response Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attachment level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Pain Experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective anxiety rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rating of fun
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrence of ovarian endometrioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in 1-hour pad weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of device related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient enrollment rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse effects measures
Endpoint domain: Adverse events/effects
Primary endpoint: Patient proportion needing radical treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage Change in Psoriasis Area and Severity Index (PASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in eating habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in body weight (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Variability in cholesterol efflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pain inhibition efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reflex decrease in muscle tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician Administered PTSD Scale (CAPS 1)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: occurrence of grade III/IV fluid retention
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of hypersensitivity reactions (HSR)
Endpoint domain: Adverse events/effects
Primary endpoint: First Occurrence of Mortality Due to Any Cause
Endpoint domain: Mortality/survival
Primary endpoint: Unplanned Hospitalization for Worsening Heart Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Life-saving Cardiovascular (CV) Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: formal counts of active acne lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Fertility Preservation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of SARS-CoV-2 infection in IBD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change in Fasting Plasma Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage Change in HbA1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage Change in Fasting Plasma Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction with the use of GenXpert
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of the Canadian Occupational Performance Measure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of the Barthel Index-based Supplementary Scales
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of the Frenchay Activities Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of the ADL domain of the Stroke Impact Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inventory of Consequences Scale for the Gambler
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: lumbar spine bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30 minute step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient accrual
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quantra Clot Time results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quantra Clot Stiffness results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reversal of metabolic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Hospital Days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidences of TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of dapagliflozin and metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observer-Rated Behavioral Anxiety at Anesthesia Induction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Boston carpal tunnel questionnaire (BCTQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Platelet Aggregation (MPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: frequency of severe hypoglycemia events
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative chest drainage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid Quantities Dispensed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Decrease in Headache Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful Ring Insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vaginal Ring Expulsion Within 48 Hours of Insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intensity of vasodilatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: post-operation infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: HBsAg Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of subjects who experience (serious) treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: potential clinically changes in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: potential clinically changes in laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of PKI and active metabolites in tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall Response After Cycle 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate After Six Cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Times a Subject Felt Sick to Her Stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Times a Subject Required Rescue Medication
Endpoint domain: Adverse events/effects
Primary endpoint: Time of relapse
Endpoint domain: Mortality/survival
Primary endpoint: CT scan results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of vaccine-related solicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve of nasal virus shedding after each dose of vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Development of serum antibody to the EbovZ GP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Asthma exacerbations (number/year)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung ultrasound scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time Zero to Last Quantifiable Time (AUC [0-last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Th17 mediated cell response modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dapivirine concentrations in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clotrimazole concentrations in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal Change in fMRI Contrast of Parameter Estimate (COPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurofilament light chain at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurofilament light chain at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported post-concussion symptoms score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Aberrant Behavior Checklist - Hyperactivity (ABC-H) Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of persistent bile leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Social Adjustment Scale (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Brief Symptom Inventory (BSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overt Aggression Scale (OAS-M)
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in time in hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Skin Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of Subjective Therapy Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Virological Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Hamilton Rating Scale for Depression (HAM-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence and Type of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Dermatologic Skin Reactions Grade 3/4
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Palmar-plantar Erythrodysesthesia (PPE) Grade 3/4
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Mucositis Grade 3
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Neutropenia Grade 3/4
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ALS Functional rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of 68Ga-DOTA-FAPI PET/MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers for prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of myocardial infarction type 4a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transfer to intensive care unit
Endpoint domain: Adverse events/effects